ArteraAI

ArteraAI is happy to announce that the #ArteraAI Prostate Test is the First-and-Only Predictive Test for Therapy Personalization in the 2024 National Comprehensive Cancer Network? (NCCN?) Guidelines? for Prostate Cancer. Our test is the only test included for its predictive performance, and also the first AI-enabled predictive and #prognostic test to be recommended in the guidelines for localized #prostatecancer. This is an exciting step forward for ArteraAI. As Andre Esteva, PhD, CEO and Co-Founder of ArteraAI said, “This significant milestone not only celebrates ArteraAI's success but also paves the way for the integration of AI-enabled solutions into clinical practice, illustrating their potential to enhance personalized patient care.” Read the announcement here:

We're proud to announce the first patient enrollment in the prospective HypoPro/HypoElect Phase II trials, using #ArteraAI MMAI to risk stratify patients with high-risk #prostatecancer and deliver precise treatments. Under the guidance of the #principalinvestigators, Dr. Constantinos Zamboglou, MHBA and Dr. Iosif Strouthos from the German Oncology Center, these trials represent an innovative approach by combining precision radiotherapy techniques and systemic therapy, tailored by AI to enhance #patientoutcomes.

What an amazing few days at #LUGPA2024! We enjoyed meeting with a ton of #urologists and sharing how the #ArteraAI Prostate Test can guide personalized treatment decision-making for patients. Looking forward to continuing the conversations with all our customers and partners at the #LUGPA Global Prostate Cancer Congress in 2025.

How can the #ArteraAI Prostate Test improve decision-making for low-risk patients? Artera CEO & Co-Founder Andre Esteva, PhD, joins Dana-Farber Cancer Institute's Alicia Morgans to discuss how the ArteraAI #ProstateTest can help clinicians decide between #activesurveillance and definitive treatment by assessing the risk of adverse pathology at #prostatectomy, and how Artera's partnership with PathNet is enabling faster delivery of results by integrating AI analysis with pathology reports, in a new video with UroToday + GU OncToday:

Get to know #ArteraAI Reda Oulbacha, Machine Learning Engineer and November Employee of the Month. "Reda excels at identifying issues and root causes in challenging situations and consistently provides solutions that exceed expectations. He is always ready to offer help and support, following up until issues are fully resolved." Congratulations, Reda! ?? We love working with you because you're the best! #personalizedcancercare #prostatecancer #AI #precisionmedicine

One of our core tenets is putting the Artera #MMAI models through extensive validation. We are proud to partner with Hackensack Meridian Health and Nitin Yerram, M.D. to investigate new clinical endpoints to better guide treatment decisions after #prostatectomy. https://heyor.ca/Spv4Mq #precisionmedicine #prostatecancer #AI #personalizedcancercare

The #ArteraAI team was thrilled to be at the Prostate Cancer Foundation #PCFRetreat2024, the foremost scientific conference in the world on the biology and treatment of #prostatecancer. Our own Emmalyn Chen, Director of Research & Publications, presented a poster with Dr. William Chen anchoring the AI model to known prostate tumor biology (e.g., AR, PSMA, CD20).

In the latest episode of Exploring Artificial Intelligence in Oncology, Dr. Waqas Haque , Oncology Fellow at the University of Chicago, sat down with Dr. Trevor Royce MD MPH FASCO, Senior Medical Director of Artera, to discuss how the #ArteraAI Prostate Test can help make personalized treatment decisions in #prostatecancer, as well as Artera's research expansion - a new #breastcancer prognostic model for early-stage breast cancer, recently presented at #ASCO24: https://lnkd.in/e87zmXBC

It's time to share some more technical insights from Artera's tech blog! Artera's tests are powered by a lot of complicated computational machinery partitioned into various virtual networks within #AWS. #ArteraAI engineer Sufiyan Ghori provides a deep dive into an issue he recently resolved and the learning and best practices recommended to avoid similar issues in the first place. https://heyor.ca/xnWUbE #GitHub #AIinfrastructure

Today is National #STEMDay - a day dedicated to science, technology, engineering, and mathematics (STEM) education/careers and a time to highlight the importance of #STEM in our world to inspire the next generation of innovators. We asked members of the Artera team to share their reasons for pursuing an interest and a career in STEM. From solving complex challenges to making a difference in the lives of others, here's what they said: #STEMSTEAMDay #NationalSTEMDay